SureScreen continues to focus on new and emerging variants of SARS-CoV-2 worldwide and closely tracks the mutant strains reported by WHO and GISAID.
Analysis of recent variants of concern including XBB, BQ.1 and BQ.1.1 indicates that the risk of the new variant(s) not being detected by the SureScreen SARS-CoV-2 Rapid Antigen Test is low.
Other variants tested and results infer to a large extent that the product is capable of detecting
B.1.617.2 (Delta), BA.1, BA.2, BA2.10, BA.2.12, BA.2.12.1, BA.4, BA.4.6 BA.5, BA.2.75, XE, BE.3, BF.7, BJ.1
